Speciality: Oncology
Description:
A warm welcome to all the medical professionals in this informative session on understanding the signs and symptoms of lymphoma. An in-depth look at the signs and symptoms of lymphoma is crucial for timely diagnosis and effective patient management. Lymphoma, a cancer of the lymphatic system, often presents with a variety of nonspecific symptoms that can be easily mistaken for other, less serious conditions. This discussion will highlight the importance of recognizing both the common and less common presentations of the disease to ensure that a thorough diagnostic workup is initiated without delay.
The most common sign of lymphoma is a painless swelling of one or more lymph nodes, typically in the neck, armpits, or groin. While swollen lymph nodes are often a response to infection, those that are persistent, firm, and not associated with a recent illness should raise suspicion. Additionally, a constellation of systemic symptoms, often referred to as "B symptoms," including unexplained fever, drenching night sweats, and significant unintentional weight loss (more than 10% of body weight over six months), are highly indicative of lymphoma and necessitate immediate investigation.
Furthermore, a deeper discussion reveals that lymphoma can affect various parts of the body beyond the lymph nodes, leading to a wide range of other signs and symptoms. For example, a lymphoma in the chest might cause a persistent cough or shortness of breath, while one in the abdomen could lead to abdominal pain, bloating, or a feeling of fullness after eating small amounts. Understanding this full spectrum of presentations is essential for medical professionals to consider lymphoma in a broad differential diagnosis, leading to earlier detection and better patient outcomes.
See More Webinars @ Hidoc Webinars
1.
Non-Factor Therapies in Hemophilia: Cutting-Edge Approaches to Individualize Care
2.
FDA approves Blenrep for relapsed or refractory multiple myeloma
3.
X-ray and radar technology combined to reduce cancer screening risks
4.
Extended Maintenance with Imatinib Enhances Disease-Free Survival in High-Risk GIST.
5.
Researchers discuss HER2-low and HER2-zero in breast cancer
1.
Understanding Mesenteric Masses: Symptoms, Diagnosis, and Treatment Options
2.
Liposomal Doxorubicin and Mitomycin in Modern Cancer Treatment
3.
The New Era of Oncology: Key Updates and Clinical Insights
4.
HIPEC in Platinum-Sensitive Ovarian Cancer: A Promising Yet Controversial Option
5.
Theranostics and Radioligand Therapy: Precision Cancer Care with Targeted Radionuclides
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Exploring Potentials of Lorlatinib: The Third Generation ALK-TKI Through CROWN Trial
2.
Managing ALK Rearranged Non-Small Cell Lung Cancer with Lorlatinib - Part I
3.
Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part V
4.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part II
5.
Expert Group meeting with the management of EGFR mutation positive NSCLC - Part III
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation